ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2022 American Transplant Congress

    Pulmonary Function Tests and Liver Transplantation

    D. Reino1, P. Martinez2, K. Robichaux3, M. Gosselin4, S. Mohammed3, J. Buggs1, A. Kumar5

    1Transplant Surgery, Tampa General Hospital, Tampa, FL, 2University of Miami, Miami, FL, 3University of South Florida, Tampa, FL, 4University of Tampa, Tampa, FL, 5Morsani College of Medicine, University of South Florida, Tampa, FL

    *Purpose: Liver transplant recipients have a high risk of developing postoperative pulmonary complications. Pulmonary function tests (PFTs) are expensive and often incapable of predicting patients…
  • 2022 American Transplant Congress

    Role of Circulating Tumour Cells in the Management of the Liver Transplant Patient with Hepatocellular Carcinoma

    F. Villalba1, F. Alconchel2, L. Sáenz3, M. Sánchez-Lorencio1, D. Ferreras2, P. Cascales2, F. Sánchez-Bueno2, R. Robles2, P. Ramírez2

    1IMIB-Virgen de la Arrixaca, Murcia, Spain, 2Surgery and Organ Transplantation, Virgen de la Arrixaca University Hospital (IMIB-Virgen de la Arrixaca), Murcia, Spain, 3Rafael Méndez Hospital, Lorca, Spain

    *Purpose: For hepatocellular carcinoma (HCC), liver transplantation (LT) is considered a curative treatment, however, more than 10% of transplant recipients have recurrences within the first…
  • 2022 American Transplant Congress

    Combined Heart-Liver Transplantation for Failing Fontan Physiology: A Large Single Center Comparative Analysis

    C. J. Rosenthal1, D. Noguchi1, J. A. Aboulhosn2, G. S. Van Arsdell3, A. Nsair4, M. Ha1, L. Reardon2, G. Lluri4, J. P. Lin4, S. Saab1, A. Baird1, R. S. Venick1, D. G. Farmer1, F. M. Kaldas1

    1Liver and Pancreas Transplant Center, UCLA, Los Angeles, CA, 2Ahmanson/UCLA Adult Congenital Heart Disease Center, UCLA, Los Angeles, CA, 3Cardiac Surgery, UCLA, Los Angeles, CA, 4Cardiology, UCLA, Los Angeles, CA

    *Purpose: The rate of combined heart-liver transplantation (HLT) has tripled in the last decade, and continues to rise along with the number of patients with…
  • 2022 American Transplant Congress

    Basiliximab Provides Similar Efficacy and Renal Recovery in Steroid-Minimal Liver Transplantation

    L. Bowman1, A. Webb1, Y. Alsalihi2, F. Fakhre3, R. Baliga4, V. Subramanian5, K. Robichaux3, S. Mohammed3, M. Gosselin6, J. Buggs5, A. Kumar7

    1Transplant Pharmacy, Tampa General Hospital, Tampa, FL, 2California Health Sciences University, Clovis, CA, 3University of South Florida, Tampa, FL, 4Florida Kidney Physicians, Tampa, FL, 5Transplant Surgery, Tampa General Hospital, Tampa, FL, 6University of Tampa, Tampa, FL, 7Morsani College of Medicine, University of South Florida, Tampa, FL

    *Purpose: Due to nephrotoxic effects of tacrolimus, previous studies have evaluated the utility of basiliximab to delay or reduce tacrolimus for renal preservation in orthotopic…
  • 2022 American Transplant Congress

    The Oncological Influences of Pre- and Post-Transplant Sustained Viral Response in Liver Transplant for Hepatocellular Carcinoma

    K. Sasaki1, S. Kimura2, K. Tomiyama3, Y. Bekki4, M. Murray3, P. Huang3, M. Fruscione2, A. Moro5, C. Kwon6

    1Stanford University, Stanford, CA, 2Massachusetts General Hospital, Boston, MA, 3University of Rochester, Rochester, NY, 4Mount Sinai Medical Center, New York, NY, 5University of South Florida, Tampa, FL, 6Cleveland Clinic, Cleveland, OH

    *Purpose: Chronic hepatitis C infection (HCV) is one of the most common causes of hepatocellular carcinoma. After emerging direct-acting agents (DAA), the success rate of…
  • 2022 American Transplant Congress

    Outcomes of Living Liver Donors Are Worse Than Those of Matched Healthy Controls: Nationwide Cohort Study

    J. Kim1, J. Choi2, J. Kim3, H. Kim4, J. Joh1

    1Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of, 2Department of Surgery, Myongji Hospital, Goyang, Korea, Republic of, 3Department of Urology, Soonchunhyang University Hospital, Soonchunhyang University College of Medicine, Seoul, Korea, Republic of, 4Department of Preventive Medicine, Korea University, Seoul, Korea, Republic of

    *Purpose: Donor death is the most serious complication of living liver donation, but is reported rarely. We investigated the actual mortality of living liver donors…
  • 2022 American Transplant Congress

    Meld/Peld Exception Policy and Outcomes in Children with Hepatopulmonary Syndrome Requiring Liver Transplantation in the United States

    M. H. Raza1, P. Kobierski1, A. Misra2, A. Lim3, C. Goldbeck2, K. Etesami2, R. Kohli4, J. Emamaullee2

    1Keck School of Medicine of USC, Los Angeles, CA, 2Surgery, University of Southern California, Los Angeles, CA, 3University of Southern California, Los Angeles, CA, 4Liver Transplant Program, Children's Hospital-Los Angeles, Los Angeles, CA

    *Purpose: Hepatopulmonary syndrome (HPS) is associated with increased waitlist mortality in liver transplant (LT) candidates. Children with HPS are currently granted MELD/PELD exception for LT…
  • 2022 American Transplant Congress

    Cytomegalovirus Prophylaxis in Pediatric Liver Transplantation: A Comparison of Strategies Across the SPLIT Consortium

    E. D. Knackstedt1, S. G. Anderson2, R. Anand2, J. Mitchell2, J. Bucuvalas3, L. Danziger-Isakov4

    1Univ of Utah/Primary Children's Hosp, SLC, UT, 2Emmes, Rockville, MD, 3Icahn School of Med at Mount Sinai, New York City, NY, 4Cincinnati Children's Hosp Med Ctr, Cincinnati, OH

    *Purpose: To compare the effectiveness of short (180d) cytomegalovirus (CMV) prophylaxis in pediatric liver transplantation (pLTX).*Methods: A prospective cohort study of primary pLTX (≤18 yrs…
  • 2022 American Transplant Congress

    Portal Vein Challenges in Pediatric Liver Transplantation: The Utility of Interposition Grafts as an Acceptable Management Strategy

    K. Etesami1, R. Hogen2, J. Cervantes3, Y. Kwon4, S. Zielsdorf3, J. Emamaullee3, Y. Genyk3

    1Surgery, Children's Hospital Los Angeles, Los Angeles, CA, 2University of Southern California, West Hollywood, CA, 3University of Southern California, Los Angeles, CA, 4Hepatobiliary and Abdominal Transplant Surgery, University of Southern California, Los Angeles, CA

    *Purpose: Portal vein (PV) anomalies and portal vein thrombosis (PVT) can present as challenging cases in the pediatric cohort, necessitating analysis and an algorithmic approach.*Methods:…
  • 2022 American Transplant Congress

    Pre-Transplant Evaluation of Patients Undergoing Combined Heart-Liver Transplantation and Correlation with Explant Pathology

    A. Shingina1, J. N. Menachem1, S. Brown1, I. A. Ziogas2, W. K. Wu3, M. J. Izzy4, J. Liang1, K. Washington1, S. Alexopoulos5

    1Vanderbilt University Medical Center, Nashville, TN, 2Division of Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, TN, 3Thoracic Surgery; Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, TN, 4GI and Hepatology, Vanderbilt University Medical Center, Nashville, TN, 5Vanderbilt Medical Center, Nashville, TN

    *Purpose: Fontan-associated liver disease (FALD) is a well-described complication of Fontan physiology. More patients with failing Fontan are being evaluated for heart transplant and evidence-based…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences